Google and Microsoft Boosts Healthcare with Major Investment in Precision Medicine Start-up
The start-up company aims to leverage its footprint in genomic data management for clinical trials through this funding. DNA nexus CEO Richard Daly asserts that “The financing enables further development and the launch of our translational medicine solutions, as well as expanding our footprint in cloud-based management of genomic data in clinical trials, Precision medicine refers to precise cloud based data driven solutions.